Anthony Wilkinson
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Professor Anthony Wilkinson is a faculty member at the University of York, UK. His research encompasses various areas including microbial pathogenesis, structural biology, and transporter proteins. Recent publications highlight his work on the mechanisms of itaconate utilization in Pseudomonas aeruginosa, as well as studies on deubiquitinases and peptide transport systems. Professor Wilkinson's contributions further extend to the investigation of virulence factors in bacteria and the potential of protein lipidation in drug discovery for leishmaniasis.
Recent Grants
Grant: Close
A global network for neglected tropical diseases
Open Date: 2018-01-01
Close Date: 2021-12-01
Grant: Close
The Role of VapA in the pathogenesis of Rhodococcus equi
Open Date: 2017-12-01
Close Date: 2020-11-01
Grant: Close
TARGeTED: Tackling Antimicrobial Resistance through Goal-orientated Thinking in the EPS Disciplines
Open Date: 2015-04-30
Close Date: 2017-10-31
Grant: Close
Integrated multi-user crystallisation facility comprising a robot and storage system with image retrieval.
Open Date: 2013-12-01
Close Date: 2018-11-30
Grant: Close
Structure-function studies of the virulence associated proteins of Rhodococcus equi
Open Date: 2012-03-31
Close Date: 2015-03-30
Articles (13)
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Rhodococcus equi is a Gram-positive facultative intracellular pathogen associated with life-threatening bronchopneumonial disease in foals. Key to R. equi’s intracellular survival in host macrophages is the production of virulence associated proteins (Vaps). Numerous vap genes are found on virulence plasmids isolated from different species, and the Vaps share a high degree of sequence identity. VapA has been extensively studied, and although vapK and vapN genes from other R. equi virulence plasmids have been shown to be essential for R. equi intracellular survival, their mode of action is less characterised. We, therefore, examined whether VapK and VapN worked mechanistically in the same way as VapA. Indeed, like VapA, VapK and VapN neutralised lysosomal pH and reduced lysosomal hydrolase activity. A loss of VapA and R. equi virulence could be regained by the presence of either VapK or VapN. The acid-neutralisation activity was also observed to a lesser extent with VapB. There was a differential activity across these virulence-promoting Vaps with the most “acid-neutralising” activity found with VapN, then VapA and K, and finally VapB. These data suggest that VapA production, which is often found in equine infections, can be substituted by VapK and B (produced by plasmids often found in porcine species) or VapN (produced by plasmids often isolated in bovine and human samples). These data imply that the molecular mechanism(s) that VapA uses to neutralise lysosomal acidity should also be seen in VapN and K which will help guide researchers in identifying their precise mode of action and aid the future development of targeted therapeutics.
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (7)
James Ronald
University of York
Maggie Smith
Professor (Emeritus)
University of York
Marjan Van Der Woude
Professor
University of York
Michelle Rudden
Lecturer (Skin Microbiome)
University of Hull
Christoph George Baumann
Lecturer in Molecular Biophysics
University of York
Gavin Hugh Thomas
Professor
University of York
Paul R. Pryor
University of York
Make your next move.
Prepare your application
Review drafts before you send them.